Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3299676012 | Hepatitis C virus NS3/4A protease inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
3745289010 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
3745291019 | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Is a | Substance with antiviral mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Has disposition | Hepatitis C virus NS3/4A protease inhibitor | true | Inferred relationship | Existential restriction modifier | ||
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Is a | Substance with protease inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Paritaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Product containing Hepatitis C virus NS3/4A protease inhibitor (product) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | 1 |
Boceprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Telaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Simeprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Grazoprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Voxilaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Glecaprevir | Is a | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Grazoprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Elbasvir + Grazoprevir | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Elbasvir 50mg / Grazoprevir 100mg tablets | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Zepatier 50mg/100mg tablets (Merck Sharp & Dohme (UK) Ltd) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Glecaprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Voxilaprevir | Is a | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Generic Vosevi 400mg/100mg/100mg tablets | Has active ingredient | False | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Vosevi 400mg/100mg/100mg tablets (Gilead Sciences Ltd) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier | |
Zepatier 50mg/100mg tablets (Originalis B.V.) | Has active ingredient | True | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets